Vadimezan, also known as DMXAA and ASA404, is a fused tricyclic analogue of flavone acetic acid with potential antineoplastic activity. Vadimezan induces the cytokines tumor necrosis alpha (TNF-alpha), serotonin and nitric oxide, resulting in hemorrhagic necrosis and a decrease in angiogenesis. This agent also stimulates the anti-tumor activity of tumor-associated macrophages.
Properties:
Density: 1.321g/cm3
Boiling Point: 520.9ºC at 760mmHg
Flash Point: 197.1ºC
Refractive Index: 1.633
Storage Condition: 2-8ºC
Vapor Pressure: 1.12E-11mmHg at 25°C
Antiviral Inhibitors Related Products:
Geldanamycin; UNC0638; U0126-EtOH; Tenofovir; Baloxavir; Tubacin; NGI-1(ML414); Emricasan; Remdesivir; Baloxavir marboxil; Famciclovir; Epigoitrin; Ribavirin